ELISA and immuno-polymerase chain reaction assays for the sensitive detection of melioidosis

Diagnostic Microbiology and Infectious Disease

Volumn 75, Issue 2, 2013, Pages 135-138

  Cooper, Alanna ^a   Williams, Natasha L ^a   Morris, Jodie L ^a   Norton, Robert E ^b   Ketheesan, Natkunam ^a   Schaeffer, Patrick M ^a  

^a JAMES COOK UNIVERSITY   (Australia)

^b TOWNSVILLE HOSPITAL   (Australia)

Author keywords

Burkholderia pseudomallei; Immuno diagnostics; Immuno PCR; Indirect haemagglutination assay; Lipopolysaccharide; Melioidosis; Serology; Tus Ter Lock

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BURKHOLDERIA PSEUDOMALLEI; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MELIOIDOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BURKHOLDERIA PSEUDOMALLEI; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MELIOIDOSIS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84872496242     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.10.011     Document Type: Article

References (23)

1. Anandan S., Augustine A., Mathai E., Jesudason M.V. Evaluation of IgM ELISA using a sonicate and a lipopolysaccharide antigen for the serodiagnosis of melioidosis. Indian J Med Microbiol 2010, 28:158-161.
2. Anuntagool N., Wuthiekanun V., White N.J., Currie B.J., Sermswan R.W., Wongratanacheewin S., et al. Lipopolysaccharide heterogeneity among Burkholderia pseudomallei from different geographic and clinical origins. Am J Trop Med Hyg 2006, 74:348-352.
3. Ashdown L.R. Indirect haemagglutination test for melioidosis. Med J Aust 1987, 147:364-365.
4. Ashdown L.R., Guard R.W. The prevalence of human melioidosis in Northern Queensland. Am J Trop Med Hyg 1984, 33:474-478.
5. Chantratita N., Wuthiekanun V., Thanwisai A., Limmathurotsakul D., Cheng A.C., Chierakul W., et al. Accuracy of enzyme-linked immunosorbent assay using crude and purified antigens for serodiagnosis of melioidosis. Clin Vaccine Immunol 2007, 14:110-113.
6. Chenthamarakshan V., Kumutha M.V., Vadivelu J., Puthucheary S.D. Distribution of immunoglobulin classes and IgG subclasses against a culture filtrate antigen of Burkholderia pseudomallei in melioidosis patients. J Med Microbiol 2001, 50:55-61.
7. Felgner P.L., Kayala M.A., Vigil A., Burk C., Nakajima-Sasaki R., Pablo J., et al. A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proc Natl Acad Sci U S A 2009, 106:13499-13504.
8. Fomsgaard A., Freudenberg M.A., Galanos C. Modification of the silver staining technique to detect lipopolysaccharide in polyacrylamide gels. J Clin Microbiol 1990, 28:2627-2631.
9. Fox J.D., Robyt J.F. Miniaurization of three carbohydrate analyses using a microsample plate reader. Anal Biochem 1991, 195:93-96.
10. Harris P.N.A., Williams N.L., Morris J.L., Ketheesan N., Norton R.E. Evidence of Burkholderia pseudomallei-specific immunity in patient sera persistently nonreactive by the indirect hemagglutination assay. Clin Vaccine Immunol 2011, 18:1288-1291.
11. Harris P.N.A., Ketheesan N., Owens L., Norton R.E. Clinical features that affect indirect-hemagglutination-assay responses to Burkholderia pseudomallei. Clin Vaccine Immunol 2009, 16:924-930.
12. Inglis T.J.J., Sagripanti J.-L. Environmental factors that affect the survival and persistence of Burkholderia pseudomallei. App Environ Microbiol 2006, 72:6865-6875.
13. Lazzaroni S.M., Barnes J.L., Williams N.L., Govan B.L., Norton R.E., LaBrooy J.T., et al. Seropositivity to Burkholderia pseudomallei does not reflect the development of cell-mediated immunity. Trans Royal Soc Trop Med Hyg 2008, 102(Suppl. 1):S66-S70.
14. Limmathurotsakul D., Peacock S.J. Melioidosis: a clinical overview. Brit Med Bull 2011, 99:125-139.
15. Limmathurotsakul D., Jamsen K., Arayawichanont A., Simpson J.A., White L.J., Lee S.J., et al. Defining the true sensitivity of culture for the diagnosis of melioidosis using Bayesian latent class models. PLoS One 2010, 5:e12485.
16. Morin I., Askin S.P., Schaeffer P.M. IgG-detection devices for the Tus-Ter-lock immuno-PCR diagnostic platform. Analyst 2011, 136:4815-4821.
17. Morin I., Dixon N.E., Schaeffer P.M. Ultrasensitive detection of antibodies using a new Tus-Ter-lock immunoPCR system. Mol Biosyst 2010, 6:1173-1175.
18. Mortz E., Krogh T.N., Vorum H., Gorg A. Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 2001, 1:1359-1363.
19. Nuti D.E., Crump R.B., Dwi Handayani F., Chantratita N., Peacock S.J., Bowen R., et al. Identification of circulating bacterial antigens by in vivo microbial antigen discovery. MBio. 2011, 2. [Epub 2011/08/19].
20. Rotz L.D., Khan A.S., Lillibridge S.R., Ostroff S.M., Hughes J.M. Public health assessment of potential biological terrorism agents. Emerging Infect Dis 2002, 8:225-230.
21. Thepthai C., Smithtikarn S., Suksuwan M., Songsivilai S., Dharakul T. Serodiagnosis of melioidosis by a competitive enzyme-linked immunosorbent assay using a lipopolysaccharide-specific monoclonal antibody. Asian Pac J Allergy Immunol 2005, 23:127-132.
22. Tuanyok A., Stone J.K., Mayo M., Kaestli M., Gruendike J., Georgia S., et al. The genetic and molecular basis of O-antigenic diversity in Burkholderia pseudomallei lipopolysaccharide. PLoS Neg Tro Dis 2012, 6:e1453.
23. White N.J. Melioidosis. Lancet 2003, 361:1715-1722.